Global News | World latest News| Trending News
Newswise — When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that depletes B cells—the immune cells that drive MS progression. Exactly how ocrelizumab does this, however, remains unclear. In a new study published in The…
Newswise — PHILADELPHIA— A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, according to findings from a team at the Perelman School of Medicine at the University of Pennsylvania published in the New England Journal of Medicine. Causing the body’s immune system to attack…
Newswise — Washington, D.C. — The Autoimmune Association is proud to announce the inaugural Hope Journey Walk, a national fundraising and awareness event that will take place on Sunday, October 12, 2025, at the Smithsonian National Zoo in Washington, D.C., and virtually across the country. Every step taken during the Autoimmune Association Hope Journey Walk…
Newswise — Philadelphia, PA — The prevalence and severity of rheumatic adverse reactions in cancer immunotherapy is significantly underestimated, due to the lack of standardized screening protocols for malignancies in patients with autoimmune disorders. In response to the need for data collection and diagnostic criteria, researchers have developed a trans-disciplinary approach to safeguard those patients…
Newswise — Some patients with lupus who possess specific antibodies are at a higher risk of thrombotic events such as a blood clot, stroke or heart attack, a new study led by Johns Hopkins Medicine researchers shows. The finding might help clinicians determine which patients may need early treatment and clinical monitoring for thrombotic events….
Newswise — COLUMBUS, Ohio – After spending years tracing the origin and migration pattern of an unusual type of immune cell in mice, researchers have shown in a new study how activity of “good” microbes in the gut is linked to rheumatoid arthritis and, potentially, other autoimmune diseases. Scientists first reported in 2016 that specific…
BYLINE: Valerie Goodwin Newswise — The sCD13 protein has been previously identified by a rheumatology research team at the University of Michigan as a powerful inducer of inflammation in multiple autoimmune disorders, such as rheumatoid arthritis and systemic sclerosis. High levels of the sCD13 protein are also now being seen in blood and lung tissues…
Newswise — For the first time, investigators are gaining a clearer understanding of what causes drug-induced antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. In a study published in The Journal of Clinical Investigation, researchers from the University of North Carolina (UNC) Department of Medicine and Kidney Center revealed that hydralazine—a drug commonly used to treat high blood pressure—alters the…
Newswise — LA JOLLA, CA—Immune system scientists and computational biologists are developing a new tool to investigate how the body fights disease. With this new resource, called ImmGenMaps, researchers are building a map of all major organs—and tracking how all types of immune cells keep those organs healthy. ImmGenMaps aims to show the body in…
Newswise — Artificial intelligence (AI) is shaping the future of health care, offering new tools for earlier diagnosis of disease and more precise tracking of treatment outcomes. In a new Yale-led study, published in Arthritis Research & Therapy, researchers used a type of AI technology called deep neural network (DNN) analysis to decipher skin involvement…
